Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$546.51
-4.79-0.87%
À la fermeture: -
$545.01
-1.50-0.27%
Après les heures de négociation: 6:57 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Intuitive Surgical Inc a un objectif de cours consensus de $530, basé sur les évaluations des 25 analystes. Le plus élevé est de $675 attribué par JP Morgan le janvier 24, 2025, et le plus bas est de $318 attribué par HSBC le novembre 17, 2023. Les 3 dernières évaluations d'analystes ont été publiées par UBS, Raymond James et Piper Sandler le octobre 23, 2025, octobre 22, 2025 et octobre 22, 2025. Avec un objectif de cours moyen de $604.33 entre UBS, Raymond James et Piper Sandler, il y a une variation implicite de 10.89% upside pour Intuitive Surgical Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
Raymond James
Piper Sandler
RBC Capital
Truist Securities
1calculé à partir des notes des analystes
Notes d'analystes pour Intuitive Surgical
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/23/2025 | 10.09% | UBS | $585 → $600 | Maintains | Neutral | |||
10/22/2025 | 10.64% | Raymond James | $592 → $603 | Maintains | Outperform | |||
10/22/2025 | 11.93% | Piper Sandler | $595 → $610 | Reiterates | Overweight → Overweight | |||
10/22/2025 | 14.68% | RBC Capital | $615 → $625 | Maintains | Outperform | |||
10/22/2025 | 13.76% | Truist Securities | $525 → $620 | Maintains | Buy | |||
10/22/2025 | 10.09% | Wells Fargo | $599 → $600 | Maintains | Overweight | |||
10/22/2025 | 8.07% | BTIG | $529 → $589 | Maintains | Buy | |||
10/15/2025 | -3.67% | Truist Securities | $600 → $525 | Maintains | Buy | |||
10/13/2025 | -2.94% | BTIG | $571 → $529 | Maintains | Buy | |||
10/07/2025 | -17.43% | Evercore ISI Group | $535 → $450 | Maintains | In-Line | |||
10/01/2025 | 4.77% | BTIG | $571 → $571 | Reiterates | Buy → Buy | |||
08/19/2025 | 12.84% | RBC Capital | $615 → $615 | Reiterates | Outperform → Outperform | |||
07/23/2025 | 7.34% | UBS | $547 → $585 | Maintains | Neutral | |||
07/23/2025 | 9.17% | Piper Sandler | $575 → $595 | Reiterates | Overweight → Overweight | |||
07/23/2025 | 10.09% | Truist Securities | $590 → $600 | Maintains | Buy | |||
07/23/2025 | 12.84% | RBC Capital | $605 → $615 | Maintains | Outperform | |||
07/23/2025 | 9.91% | Wells Fargo | $559 → $599 | Maintains | Overweight | |||
07/23/2025 | 4.77% | BTIG | $566 → $571 | Maintains | Buy | |||
07/08/2025 | 0.92% | Evercore ISI Group | $470 → $550 | Maintains | In-Line | |||
06/09/2025 | -19.27% | Deutsche Bank | $515 → $440 | Downgrade | Hold → Sell | |||
05/22/2025 | 19.26% | Citigroup | $590 → $650 | Maintains | Buy | |||
04/24/2025 | 16.51% | Barclays | $684 → $635 | Maintains | Overweight | |||
04/23/2025 | 11.01% | RBC Capital | $630 → $605 | Maintains | Outperform | |||
04/23/2025 | 8.26% | Truist Securities | $605 → $590 | Maintains | Buy | |||
04/23/2025 | 5.5% | Piper Sandler | $670 → $575 | Maintains | Overweight | |||
04/23/2025 | -13.76% | Evercore ISI Group | $510 → $470 | Maintains | In-Line | |||
04/23/2025 | 5.5% | Baird | $600 → $575 | Maintains | Outperform | |||
03/18/2025 | 10.09% | Baird | $707 → $600 | Maintains | Outperform | |||
03/17/2025 | 11.01% | Truist Securities | $666 → $605 | Maintains | Buy | |||
01/24/2025 | 7.34% | Deutsche Bank | $505 → $585 | Maintains | Hold | |||
01/24/2025 | 22.2% | Truist Securities | $640 → $666 | Maintains | Buy | |||
01/24/2025 | 26.24% | Raymond James | $560 → $688 | Maintains | Outperform | |||
01/24/2025 | 22.93% | Piper Sandler | $538 → $670 | Reiterates | Overweight → Overweight | |||
01/24/2025 | 26.05% | Wells Fargo | $630 → $687 | Maintains | Overweight | |||
01/24/2025 | 30.46% | Citigroup | $640 → $711 | Maintains | Buy | |||
01/24/2025 | 23.85% | JP Morgan | $575 → $675 | Maintains | Overweight | |||
12/18/2024 | 17.43% | Truist Securities | $570 → $640 | Maintains | Buy | |||
12/11/2024 | 17.43% | Citigroup | $567 → $640 | Maintains | Buy | |||
12/11/2024 | 15.59% | Wells Fargo | $549 → $630 | Maintains | Overweight | |||
12/05/2024 | 11.93% | Stifel | $525 → $610 | Maintains | Buy | |||
12/02/2024 | 19.26% | Morgan Stanley | $522 → $650 | Upgrade | Equal-Weight → Overweight | |||
11/26/2024 | 2.93% | BTIG | $535 → $561 | Maintains | Buy | |||
11/19/2024 | — | Erste Group | — | Upgrade | Hold → Buy | |||
10/18/2024 | -10.09% | Evercore ISI Group | $475 → $490 | Maintains | In-Line | |||
10/18/2024 | -1.84% | BTIG | $518 → $535 | Maintains | Buy | |||
10/18/2024 | -1.29% | Piper Sandler | $495 → $538 | Reiterates | Overweight → Overweight | |||
10/18/2024 | -3.67% | Stifel | $475 → $525 | Maintains | Buy | |||
10/18/2024 | 0.73% | Wells Fargo | $466 → $549 | Maintains | Overweight | |||
10/18/2024 | 1.83% | RBC Capital | $525 → $555 | Maintains | Outperform | |||
10/18/2024 | 3.67% | Baird | $503 → $565 | Maintains | Outperform | |||
10/14/2024 | -0.92% | Raymond James | $500 → $540 | Maintains | Outperform | |||
10/14/2024 | -4.96% | BTIG | $494 → $518 | Maintains | Buy | |||
10/14/2024 | 4.59% | Truist Securities | $520 → $570 | Maintains | Buy | |||
10/11/2024 | 5.5% | JP Morgan | $495 → $575 | Maintains | Overweight | |||
10/08/2024 | -3.67% | RBC Capital | $515 → $525 | Maintains | Outperform | |||
10/01/2024 | -12.85% | Evercore ISI Group | $410 → $475 | Maintains | In-Line | |||
08/28/2024 | -9.36% | BTIG | $469 → $494 | Maintains | Buy | |||
08/22/2024 | 2.75% | Citigroup | $512 → $560 | Maintains | Buy | |||
08/02/2024 | -6.42% | Redburn Atlantic | $380 → $510 | Upgrade | Neutral → Buy | |||
07/23/2024 | -6.42% | Barclays | $490 → $510 | Maintains | Overweight | |||
07/19/2024 | -9.18% | JP Morgan | $475 → $495 | Maintains | Overweight | |||
07/19/2024 | -12.85% | Morgan Stanley | $460 → $475 | Maintains | Equal-Weight | |||
07/19/2024 | -4.59% | Truist Securities | $515 → $520 | Maintains | Buy | |||
07/19/2024 | -13.95% | BTIG | $459 → $469 | Maintains | Buy | |||
07/19/2024 | -24.77% | Evercore ISI Group | $425 → $410 | Maintains | In-Line | |||
07/19/2024 | -12.85% | Stifel | $430 → $475 | Maintains | Buy | |||
07/19/2024 | -9.18% | Piper Sandler | $490 → $495 | Maintains | Overweight | |||
07/19/2024 | -7.71% | Baird | $487 → $503 | Maintains | Outperform | |||
07/18/2024 | -10.09% | Barclays | $430 → $490 | Maintains | Overweight | |||
07/16/2024 | -5.51% | Truist Securities | $450 → $515 | Maintains | Buy | |||
07/15/2024 | -15.78% | BTIG | $451 → $459 | Maintains | Buy | |||
07/15/2024 | -15.6% | Morgan Stanley | $375 → $460 | Maintains | Equal-Weight | |||
07/10/2024 | -6.06% | Citigroup | $462 → $512 | Maintains | Buy | |||
07/09/2024 | -10.09% | Piper Sandler | $435 → $490 | Maintains | Overweight | |||
07/02/2024 | -22.02% | Evercore ISI Group | $385 → $425 | Maintains | In-Line | |||
05/30/2024 | -8.26% | Goldman Sachs | → $500 | Initiates | → Buy | |||
04/19/2024 | -22.75% | BTIG | $412 → $421 | Maintains | Buy | |||
04/19/2024 | -20.18% | Piper Sandler | $425 → $435 | Maintains | Overweight | |||
04/19/2024 | -31.19% | Jefferies | $365 → $375 | Maintains | Hold | |||
04/19/2024 | -20% | Baird | $440 → $436 | Maintains | Outperform | |||
04/08/2024 | -21.1% | Stifel | $420 → $430 | Maintains | Buy | |||
04/03/2024 | -15.23% | Citigroup | $428 → $462 | Maintains | Buy | |||
03/15/2024 | -22.94% | Stifel | → $420 | Reiterates | Buy → Buy | |||
01/25/2024 | -28.44% | Mizuho | $350 → $390 | Maintains | Neutral | |||
01/25/2024 | -21.1% | Barclays | $385 → $430 | Maintains | Overweight | |||
01/25/2024 | -20.18% | Raymond James | $372 → $435 | Maintains | Outperform | |||
01/24/2024 | -20.74% | RBC Capital | $400 → $432 | Maintains | Outperform | |||
01/24/2024 | -22.94% | Stifel | $360 → $420 | Maintains | Buy | |||
01/24/2024 | -20.18% | Truist Securities | $390 → $435 | Maintains | Buy | |||
01/24/2024 | -22.02% | Piper Sandler | $325 → $425 | Maintains | Overweight | |||
01/19/2024 | -23.67% | Wells Fargo | $363 → $416 | Maintains | Overweight | |||
01/12/2024 | -26.61% | RBC Capital | $380 → $400 | Maintains | Outperform | |||
01/03/2024 | -31.74% | Raymond James | $310 → $372 | Maintains | Outperform | |||
12/22/2023 | -28.44% | Truist Securities | $375 → $390 | Maintains | Buy | |||
12/12/2023 | -31.19% | Truist Securities | $320 → $375 | Maintains | Buy | |||
12/04/2023 | -39.45% | Morgan Stanley | $300 → $330 | Maintains | Equal-Weight | |||
11/17/2023 | -35.78% | Stifel | $315 → $350 | Maintains | Buy | |||
11/17/2023 | -41.65% | HSBC | → $318 | Initiates | → Buy | |||
10/23/2023 | -44.95% | Morgan Stanley | $330 → $300 | Maintains | Equal-Weight | |||
10/20/2023 | -40.37% | Piper Sandler | $385 → $325 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action Intuitive Surgical (ISRG) ?
Le dernier objectif de prix pour Intuitive Surgical (NASDAQ:ISRG) a été rapporté par UBS le octobre 23, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $600.00 s'attendant à ce que ISRG se rise dans les 12 prochains mois (un possible changement de 10.09% upside). 43 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Intuitive Surgical (ISRG) ?
La dernière note d'analyste pour Intuitive Surgical (NASDAQ:ISRG) a été fournie par UBS, et Intuitive Surgical maintenu leur note neutral.
Quand a eu lieu la dernière mise à niveau pour Intuitive Surgical (ISRG) ?
La dernière amélioration pour Intuitive Surgical Inc a eu lieu le décembre 2, 2024 lorsque Morgan Stanley a augmenté leur objectif de prix à $650. Morgan Stanley avait précédemment an equal-weight pour Intuitive Surgical Inc.
Quand a eu lieu la dernière dégradation pour Intuitive Surgical (ISRG) ?
La dernière réduction pour Intuitive Surgical Inc a eu lieu le juin 9, 2025 lorsque Deutsche Bank a changé leur objectif de prix de $515 à $440 pour Intuitive Surgical Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Intuitive Surgical (ISRG) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Intuitive Surgical, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Intuitive Surgical a été déposée le octobre 23, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 23, 2026.
La note d'analyste pour Intuitive Surgical (ISRG) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Intuitive Surgical (ISRG) était un maintenu avec un objectif de prix de $585.00 à $600.00. Le prix actuel de Intuitive Surgical (ISRG) est de $545.01, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.